SCHEMBL159593

SCHEMBL159593

O=C(CS)N1CC[N]CC1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
LMNA P02545 2/20 0.34
ATM Q13315 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
CPN1 P15169 1/20 0.30
CPB2 Q96IY4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11559490 0.82 ALDH1A1 (0.48) ALDH1A1HSD17B10LMNAATMKDM4E
SCHEMBL28856427 0.82
SCHEMBL4257 0.78 AKR1C3 (0.37) ALDH1A1HSD17B10LMNAATMKDM4E
SCHEMBL4741470 0.77
SCHEMBL8133040 0.77
SCHEMBL7508583 0.76 ALDH1A1 (0.34) ALDH1A1HSD17B10LMNAATMKDM4E
SCHEMBL5348 0.76 BLM (0.44) ALDH1A1LMNAMEN1HPGDKMT2A
SCHEMBL3316084 0.76 CPN1 (0.41) ALDH1A1HSD17B10LMNAATMKDM4E
SCHEMBL3549871 0.76 ALDH1A1 (0.52) ALDH1A1HSD17B10LMNAATMKDM4E
SCHEMBL7511019 0.76 ALDH1A1 (0.44) ALDH1A1HSD17B10LMNAATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11072793-B2 DsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups SAREPTA THERAPEUTICS, INC. (US) 2021-07-27 US claimed
US-20190169611-A1 dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2019-06-06 US claimed
US-10017763-B2 dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups SAREPTA THERAPEUTICS, INC. (US) 2018-07-10 US claimed
US-20130288369-A1 dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS SAREPTA THERAPEUTICS, INC. (US) 2013-10-31 US claimed
WO-2012031243-A2 dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS AVI BIOPHARMA, INC. (US) 2012-03-08 WO claimed
US-11072793-B2 DsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups SAREPTA THERAPEUTICS, INC. (US) 2021-07-27 US disclosed
US-20190169611-A1 dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2019-06-06 US disclosed
US-10017763-B2 dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups SAREPTA THERAPEUTICS, INC. (US) 2018-07-10 US disclosed
US-20130288369-A1 dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS SAREPTA THERAPEUTICS, INC. (US) 2013-10-31 US disclosed
WO-2012031243-A2 dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS AVI BIOPHARMA, INC. (US) 2012-03-08 WO disclosed